Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06551324
What this trial is testing

Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer 600
Early research (Phase 1)UnknownNCT05533203
What this trial is testing

Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Shanghai Humantech Biotechnology Co. Ltd 24
Early research (Phase 1)Active Not RecruitingNCT04662580
What this trial is testing

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 183
Post-approval studies (Phase 4)Study completedNCT03927391
What this trial is testing

Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Radboud University Medical Center 57
Not applicableStudy completedNCT03526562
What this trial is testing

Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients

Who this might be right for
Prostatic NeoplasmsExerciseCastration-resistant Prostate Cancer+1 more
University Hospital, Ghent 9
Early research (Phase 1)Looking for participantsNCT05818683
What this trial is testing

Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate NeoplasmsMetastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC 300
Not applicableUnknownNCT03177551
What this trial is testing

Predictive Nomogram of CRPC

Who this might be right for
Castration-resistant Prostate CancerMetastatic Cancer
Tianjin Medical University Second Hospital 300
Testing effectiveness (Phase 2)Looking for participantsNCT03972657
What this trial is testing

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 345
Early research (Phase 1)Active Not RecruitingNCT06229366
What this trial is testing

[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Castration-resistant Prostate CancerOligometastatic Prostate Carcinoma+1 more
Eli Lilly and Company 142
Early research (Phase 1)Ended earlyNCT03792841
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer
Amgen 212
Large-scale testing (Phase 3)Ended earlyNCT02057666
What this trial is testing

Study Of Tasquinimod In Asian Chemo-Naïve Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Ipsen 146
Testing effectiveness (Phase 2)Study completedNCT00878436
What this trial is testing

Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration

Who this might be right for
Prostate CancerProstatic Neoplasms
NYU Langone Health 52
Testing effectiveness (Phase 2)Study completedNCT01848067
What this trial is testing

Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Early research (Phase 1)Study completedNCT03276572
What this trial is testing

Phase I Trial of 225Ac-J591 in Patients With mCRPC

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 32
Early research (Phase 1)Study completedNCT03776968
What this trial is testing

A Study Evaluating HC-1119 Single-Dose Pharmacokinetics and Effect of Food on Its Pharmacokinetics

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Hinova Pharmaceuticals Inc. 47
Early research (Phase 1)Ended earlyNCT04541225
What this trial is testing

Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors

Who this might be right for
GliomaGlioma, MalignantGlioma, Mixed+21 more
Nuvation Bio Inc. 74
Early research (Phase 1)Looking for participantsNCT07533708
What this trial is testing

A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours

Who this might be right for
mCRPC or Advanced/Metastatic Solid Tumors
Shanghai Henlius Biotech 48
Testing effectiveness (Phase 2)Study completedNCT01174368
What this trial is testing

Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T

Who this might be right for
Prostate Cancer
The Rogosin Institute 1
Early research (Phase 1)Active Not RecruitingNCT02592317
What this trial is testing

Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Aragon Pharmaceuticals, Inc. 23
Testing effectiveness (Phase 2)WithdrawnNCT01478308
What this trial is testing

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
New Mexico Cancer Research Alliance
Next Page